#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Search results: (278)



Journal articles PCSK9 inhibitors in the management of patients with high cardiovascular risk – effective treatment to reach

Author of the article: Ľubomíra Fábryová Source: Athero Review | 1/2016 15. 2. 2016

Journal articles Cardiovascular risk in patients with familial hypercholesterolemia. Do we rate it correctly?

Author of the article: Ubomíra Fábryová Source: Athero Review | 2/2020 11. 5. 2020

Journal articles How media affect fat choice

Author of the article: Jiří Brát Source: Athero Review | 2/2020 11. 5. 2020

Journal articles Genetic testing for early prediction of cardiovascular diseases: genome-wide association studies and polygenic score

Author of the article: Jaroslav A. Hubáček Source: Athero Review | 2/2020 11. 5. 2020

Journal articles Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

Author of the article: Robert, Hegele, Jan Borén, Henry N Ginsberg, Marcello Arca, Maurizio Averna, Christoph J Binder, Laura Calabresi, M. John Chapman, Marina Cuchel, Arnold Von Eckardstein, Ruth Frikke-Schmidt, Daniel Gaudet, G. Kees Hovingh, Florian Kronenberg, Dieter Lütjohann, Klaus G Parhofer, Frederick J Raal, Kausik K Ray, Alan T Remaley, Jane K Stock, Erik S Stroes, Lale Tokgözo Lu, Alberico L Catapano Source: Athero Review | Supplementum 1/2021 31. 3. 2021

Journal articles SGLT2 inhibitors and atherosclerosis in a background of effect of gliflozins and heart failure

Author of the article: Josef Kořínek, Miloš Dobiáš Source: Athero Review | 2/2021 22. 6. 2021

Journal articles Atherosclerosis – indicator for treatment of patient with type 2 diabetes mellitus

Author of the article: Katarína Rašlová Source: Athero Review | 2/2021 22. 6. 2021

Journal articles GLP-1 receptor agonists: antidiabetic agents with antiatherogenic effect

Author of the article: Ivan Tkáč Source: Athero Review | 3/2020 1. 7. 2020

Journal articles New alirocumab dosing regimen: 300 mg every 4 weeks

Author of the article: Petr Ošťádal Source: Athero Review | 2/2021 22. 6. 2021

Journal articles Antiatherosclerotic and antiinflammatory activities of SGLT2 inhibitors

Author of the article: Ján Murín Source: Athero Review | 1/2021 10. 2. 2021

Journal articles Apolipoprotein L1 – ethnically specific determinant of renal and heart failure

Author of the article: Jaroslav A. Hubáček Source: Athero Review | 3/2019 16. 10. 2019

Journal articles 28PS Detekce eozinofilních granulocytů v lidské tukové tkáni a jejich vztah ke kardiovaskulárním rizikovým faktorům: pilotní studie

Author of the article: Paukner K, Bartušková H, Froněk J, Kauerová S, Muffová B, Poledne R, Králová Lesná I Source: Athero Review | Supplementum 2/2021 20. 10. 2021

Journal articles 31PS Metabolické a renoprotektivní účinky empagliflozinu u spontánně hypertenzních potkanů exprimujících lidský C-reaktivní protein

Author of the article: Šilhavý J, Mlejnek P, Šimáková M, Hüttl M, Marková I, Malinská H, Vaněčková I, Pravenec M Source: Athero Review | Supplementum 2/2021 20. 10. 2021

Journal articles 30PS Vliv obezity na obsah tuku v játrech a hladinu VLDL po 60hodinovém hladovění

Author of the article: Šedivý P, Kovář J, Dusilová T, Krauzová E, Šiklová M, Dezortová M Source: Athero Review | Supplementum 2/2021 20. 10. 2021

Journal articles 29PS Analýza spektra plazmatických žlučových kyselin u cholesterolové cholelitiázy

Author of the article: Staňková B, Vecka M, Frýba V, Žák A, Tomášová P Source: Athero Review | Supplementum 2/2021 20. 10. 2021

Journal articles Important current information of consensus statement of EAS on low-density lipoproteins: editorial

Author of the article: Rudolf Poledne Source: Athero Review | 1/2021 10. 2. 2021

Journal articles Low concentration of plasma cholesterol and type 2. diabetes mellitus

Author of the article: Jaroslav A. Hubáček Source: Athero Review | 1/2021 10. 2. 2021

Journal articles Why we need to improve serum levels of cholesterol after percutanneous coronary intervention

Author of the article: Ján Murín, Jozef Bulas, Martin Wawruch, Alexander Klabník, Udovít Gašpar Source: Athero Review | 1/2021 10. 2. 2021

Journal articles 25PS Zhoršený metabolizmus lipidů a cytochromu P450 v játrech předchází dyslipidemii v séru u postmenopauzálního metabolického syndromu

Author of the article: Marková I, Hüttl M, Miklanková D, Zapletalová I, Poruba M, Malinská H Source: Athero Review | Supplementum 2/2021 20. 10. 2021

Journal articles Familial dysbetalipoproteinemia: known unknown

Author of the article: Martin Šatný, Tereza Altschmiedová, Veronika Todorovová, Ondřej Kyselák, Vladimír Soška, Michal Vrablík Source: Athero Review | 1/2022 11. 3. 2022

Journal articles Immuno-thrombosis, coagulopathy, pulmonary embolism and diagnosis in patients with COVID-19

Author of the article: Miloš Dobiáš, Jan Lami, Lenka Bukovská, Josef Kořínek Source: Athero Review | 1/2022 11. 3. 2022

Journal articles A diabetologist‘s view on the metabolic surgery in the treatment of patients with type 2 diabetes

Author of the article: Martin Haluzík Source: Athero Review | 1/2017 14. 2. 2017

Journal articles Research on remarkable articles from international literature

Author of the article: Eva Tůmová Source: Athero Review | 1/2022 11. 3. 2022

Journal articles LipitenCliDec Study – the profile of patients with uncontrolled arterial hypertension and/or dyslipidemia in primary care in the Czech Republic: the 2nd phase results

Author of the article: Martin Šatný, Eva Tůmová, Michal Vrablík, Jana Mašková, Jiří Laštůvka Source: Athero Review | 2/2020 11. 5. 2020

Journal articles Uric acid and influence of hyperuricaemia therapy on prevention of atheroscleroris and cardiovascular diseases

Author of the article: Ubica Cibičková, Martin Žurek Source: Athero Review | 1/2020 12. 2. 2020

1 2 3 4 5 12
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#